1-5 of 5
jean Sebastien Blade
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter Open Label Phase 2 Study of Quadruplet-Based Regimen Iskpd (isatuximab plus pomalidomide and dexamethasone with carfilzomib) in Early Relapsed or Refractory Multiple Myeloma - IFM2018-03

Arthur Bobin, Jerome Lambert, Stéfanie Ragot, Aurore Perrot, Salomon Manier, Lionel Karlin, Denis Caillot, Lotfi Benboubker, Thomas Chalopin, Carla Araujo, Jean Fontan, Thorsten Braun, Clara Mariette, Elodie Scherman, Olivier Decaux, jean Sebastien Blade, Faiza Keddar, Christophe Roul, Mamoun Dib, Jill Corre, Frederique Orsini Piocelle, Laure Vincent, Cyrille Touzeau, Philippe Moreau, Herve Avet Loiseau, Xavier Leleu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6742.
https://doi.org/10.1182/blood-2023-185792
Published: 2023
Journal Articles

Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma. Iskpd - IFM2018-03

Arthur Bobin, Jerome Lambert, Stéphanie Ragot, Aurore Perrot, Salomon Manier, Lionel Karlin, Denis Caillot, Cyrille Hulin, Lotfi Benboubker, Carla Araujo, Jean Fontan, Thorsten Braun, Clara Mariette, Elodie Scherman, Olivier Decaux, jean Sebastien Blade, Faida Keddar, Christophe Roul, Mamoun Dib, Jill Corre, Frederique Orsini, Laure Vincent, Mohamad Mohty, Cyrille Touzeau, Philippe Moreau, Herve Avet Loiseau, Xavier Leleu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4452–4453.
https://doi.org/10.1182/blood-2022-166870
Published: 2022
Journal Articles

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Marie-Lorraine Chretien, Jill Corre, Valerie Lauwers-Cances, Florence Magrangeas, Alice Cleynen, Edwige Yon, Cyrille Hulin, Xavier Leleu, Frederique Orsini-Piocelle, Jean-Sebastien Blade, Claudine Sohn, Lionel Karlin, Xavier Delbrel, Benjamin Hebraud, Murielle Roussel, Gerald Marit, Laurent Garderet, Mohamad Mohty, Philippe Rodon, Laurent Voillat, Bruno Royer, Arnaud Jaccard, Karim Belhadj, Jean Fontan, Denis Caillot, Anne-Marie Stoppa, Michel Attal, Thierry Facon, Philippe Moreau, Stephane Minvielle, Hervé Avet-Loiseau
Journal: Blood
Blood (2015) 126 (25): 2713–2719.
https://doi.org/10.1182/blood-2015-06-650242
Published: 2015
Includes: Supplemental data
Journal Articles

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Brief Report
Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sebastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie-Christine Bene, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2012) 119 (11): 2474–2477.
https://doi.org/10.1182/blood-2011-11-390781
Published: 2012
Journal Articles

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Patrice Chevallier, MD, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, MD, PhD, Sébastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, MD, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 1525.
https://doi.org/10.1182/blood.V118.21.1525.1525
Published: 2011